Trial Profile
Clinical Trial of Zocor and Vytorin in Adolescents With Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Simvastatin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 24 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Dec 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 03 Jul 2007 New trial record.